このエントリーをはてなブックマークに追加
ID 66884
FullText URL
fulltext.pdf 4.25 MB
Author
Taniguchi, Rikako Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Moriya, Yuto Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Dohmae, Naoshi Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science
Suzuki, Takehiro Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science
Nakahara, Kengo Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Kubota, Sho Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Takasugi, Nobumasa Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Uehara, Takashi Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID
Abstract
Upregulation of nitric oxide (NO) production contributes to the pathogenesis of numerous diseases via S-nitro- sylation, a post-translational modification of proteins. This process occurs due to the oxidative reaction between NO and a cysteine thiol group; however, the extent of this reaction remains unknown. S-Nitrosylation of PRMT1, a major asymmetric arginine methyltransferase of histones and numerous RNA metabolic proteins, was induced by NO donor treatment. We found that nitrosative stress leads to S-nitrosylation of cysteine 119, located near the active site, and attenuates the enzymatic activity of PRMT1. Interestingly, RNA sequencing analysis revealed similarities in the changes in expression elicited by NO and PRMT1 inhibitors or knockdown. A comprehensive search for PRMT1 substrates using the proximity-dependent biotin identification method highlighted many known and new substrates, including RNA-metabolizing enzymes. To validate this result, we selected the RNA helicase DDX3 and demonstrated that arginine methylation of DDX3 is induced by PRMT1 and attenuated by NO treatment. Our results suggest the existence of a novel regulatory system associated with transcription and RNA metabolism via protein S-nitrosylation.
Keywords
Nitric oxide
S-Nitrosylation
Protein arginine methyltransferase 1 (PRMT1)
RNA metabolism
Dead-box helicase 3X-linxed (DDX3)
Published Date
2024-03
Publication Title
Journal of Pharmacological Sciences
Volume
volume154
Issue
issue3
Publisher
Japanese Pharmacological Society
Start Page
209
End Page
217
ISSN
1347-8613
NCID
AA11806667
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2024 The Authors.
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1016/j.jphs.2023.12.012
License
http://creativecommons.org/licenses/by-nc-nd/4.0/
Funder Name
Ministry of Education, Culture, Sports, Science and Technology
Smoking Research Foundation
Japan Science and Technology Agency
助成番号
22K19380
JPMJSP2126